What It's like to have sepsis and kidney damage: patients share their stories
NCT ID NCT07180238
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study interviewed 28 people who had sepsis-associated acute kidney injury (SA-AKI) to learn about their symptoms, impacts, and treatment experiences. Participants shared their perspectives in 60-minute interviews. The goal was to better understand what patients go through, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
28 people
The number who actually took part.
- Started
-
May 2025
- Finished
-
Sep 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults who have experienced SA-AKI. A subset of the interviews (50%-70%) will include a caregiver/care-partner in a dyad interview (a type of interview that involves two respondents). In addition, the study team targets for a minimum of 50% of participants that have been diagnosed with SA-AKI no longer than 5 years ago.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Potential participants who were diagnosed with SA-AKI (KDIGO stage I, II or III) must meet the following eligibility criteria: * ≥18 to ≤ 85 years of age * First diagnosis of SA-AKI at least 6 months prior to screening date, but no more than 10 years * Admitted due to sepsis and/or AKI to intensive care unit (ICU), intermediate care unit (IMCU), or high-dependency care unit, or developed sepsis and/or AKI during their inpatient hospital stay. * Resident of country of study (US or Germany) * Access to computer, tablet, or smartphone with internet connection * Willing to participate in an audio recorded interview Participants will be required to present confirmation of diagnosis (COD) rather than relying on a self-reported diagnosis. Sepsis and AKI diagnoses will be confirmed through one of the following: * Copy of medical records (e.g., portable document format \[PDF\] file of electronic health record) * Physician confirmation of diagnosis of sepsis and AKI (post-sepsis) Potential caregiver participants must meet the following criteria: * ≥18 to ≤ 85 years of age * Primary caregiver/care-partner for eligible participant who experienced SA-AKI * Resident of country of study (US or Germany) * Access to computer, tablet, or smartphone with internet connection * Willing to participate in an audio recorded interview Exclusion Criteria: Potential participants are not eligible if they meet any of the following criteria: * Less than age of majority in locality (Participant is not considered an adult in their country or region) * Not willing to participate in an audio recorded interview * Not able to participate in the interview or complete required study surveys, based on the discretion of the study team
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sepsis-associated acute kidney injury are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Novartis Investigative Site
East Hanover, New Jersey, 07936-1080, United States